INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

BBNXBeta Bionics, Inc.

CIK 0001674632

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 48
Max Insider Score51
Connections10with evidence

BBNX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,253
370 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Insider ofevidence
    Russell Steven JonChief Medical Officer · Mar 16, 2026
  • ← Insider ofevidence
    Hopman MarkChief Commercial Officer · Mar 5, 2026
  • ← Insider ofevidence
    Dearen Danny L.Director · Jan 14, 2026
6
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL
$58K
2,650 sh
Oct 27, 2026
Oct 29, 2026
traded Oct 27, 2026
+2d
SEC FORM 4

Evidence

3
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$16K
821 sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC FORM 4

Evidence

19
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$13K
775 sh
Oct 14, 2026Oct 16, 2026
traded Oct 14, 2026
+2dSEC FORM 4

Evidence

19
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$7,015
370 sh
Oct 1, 2026Oct 5, 2026
traded Oct 1, 2026
+4dSEC FORM 4

Evidence

22
JC
Jones ChristyDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$148K
6,430 sh
Sep 22, 2026Sep 23, 2026
traded Sep 22, 2026
+1dSEC FORM 4

Evidence

16
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
2,650 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC FORM 4

Evidence

27
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$620K
30.8K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC FORM 4

Evidence

13
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
775 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC FORM 4

Evidence

27
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$681K
36.9K sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC FORM 4

Evidence

19
SS
Saint SeanDirector, President & CEO
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$113K
5,641 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC FORM 4

Evidence

38
SS
Saint SeanDirector, President & CEO
BBNXBeta Bionics, Inc.
Open-market sale
SELL$322K
16.9K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC FORM 4

Evidence

35
RJ
Russell Steven JonChief Medical Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$81K
4,221 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC FORM 4

Evidence

35
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$128K
6,675 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC FORM 4

Evidence

32
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$102K
5,327 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC FORM 4

Evidence

35
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$84K
4,375 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC FORM 4

Evidence

0
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Option exercise · 10b5-1 plan
M$25K
4,896 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

14
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
4,896 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

0
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Option exercise · 10b5-1 plan
M—
4,982 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

0
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Option exercise · 10b5-1 plan
M—
4,896 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

0
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Option exercise · 10b5-1 plan
M$25K
4,982 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

14
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$87K
5,104 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

15
JC
Jones ChristyDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
1,406 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC FORM 4

Evidence

11
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
1,258 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC FORM 4

Evidence

16
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,385
275 sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC FORM 4

Evidence

20
JC
Jones ChristyDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
2,811 sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC FORM 4

Evidence

35
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$84K
6,676 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC FORM 4

Evidence

35
SS
Saint SeanDirector, President & CEO
BBNXBeta Bionics, Inc.
Open-market sale
SELL$213K
16.9K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC FORM 4

Evidence

35
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$55K
4,378 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC FORM 4

Evidence

35
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$67K
5,329 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC FORM 4

Evidence

35
RJ
Russell Steven JonChief Medical Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$53K
4,222 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC FORM 4

Evidence

16
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
998 sh
May 22, 2026May 26, 2026
traded May 22, 2026
+4dSEC FORM 4

Evidence

13
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Grant or award · 10b5-1 plan
A—
17.0K sh
May 21, 2026May 26, 2026
traded May 21, 2026
+5dSEC FORM 4

Evidence

26
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,950
1,000 sh
May 21, 2026May 26, 2026
traded May 21, 2026
+5dSEC FORM 4

Evidence

17
JC
Jones ChristyDirector
BBNXBeta Bionics, Inc.
Grant or award · 10b5-1 plan
A—
17.0K sh
May 21, 2026May 26, 2026
traded May 21, 2026
+5dSEC FORM 4

Evidence

30
JC
Jones ChristyDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
1,998 sh
May 21, 2026May 26, 2026
traded May 21, 2026
+5dSEC FORM 4

Evidence

34
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$63K
2,061 sh
Dec 4, 2025Mar 16, 2026
traded Dec 4, 2025
+102dSEC FORM 4

Evidence

51
RJ
Russell Steven JonChief Medical Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$30K
1,025 sh
Dec 2, 2025Mar 16, 2026
traded Dec 2, 2025
+104dSEC FORM 4

Evidence

35
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
856 sh
Dec 2, 2025Mar 16, 2026
traded Dec 2, 2025
+104dSEC FORM 4

Evidence

1
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$4,084
353 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

17
DL
Dearen Danny L.Director
BBNXBeta Bionics, Inc.
Grant or award
A—
3,997 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC FORM 4

Evidence

13
PM
Palasis MariaDirector
BBNXBeta Bionics, Inc.
Grant or award
A—
3,997 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC FORM 4

Evidence

13
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Grant or award
A—
3,997 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC FORM 4

Evidence

17
JC
Jones ChristyDirector
BBNXBeta Bionics, Inc.
Grant or award
A—
3,997 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC FORM 4

Evidence

9
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
2,200 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC FORM 4

Evidence

13
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$213K
7,200 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC FORM 4

Evidence

20
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$591K
20.0K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC FORM 4

Evidence

6
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
600 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC FORM 4

Evidence

7
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Option exercise · 10b5-1 plan
M—
20.0K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC FORM 4

Evidence

6
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Option exercise · 10b5-1 plan
M$102K
20.0K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC FORM 4

Evidence

36
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$42K
1,427 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC FORM 4

Evidence

36
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$31K
1,063 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC FORM 4

Evidence

39
SS
Saint SeanDirector, President & CEO
BBNXBeta Bionics, Inc.
Open-market sale
SELL$96K
3,278 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC FORM 4

Evidence

20
PM
Palasis MariaDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
500 sh
Dec 1, 2025Dec 2, 2025
traded Dec 1, 2025
+1dSEC FORM 4

Evidence

20
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
906 sh
Dec 1, 2025Dec 2, 2025
traded Dec 1, 2025
+1dSEC FORM 4

Evidence

20
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
500 sh
Dec 1, 2025Dec 2, 2025
traded Dec 1, 2025
+1dSEC FORM 4

Evidence

20
PM
Palasis MariaDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
906 sh
Dec 1, 2025Dec 2, 2025
traded Dec 1, 2025
+1dSEC FORM 4

Evidence

16
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$1,053
38 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC FORM 4

Evidence

16
PM
Palasis MariaDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,267
119 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC FORM 4

Evidence

20
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
1,368 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Jones ChristyDirector · Jan 14, 2026
  • ← Insider ofevidence
    Saint SeanDirector, President & CEO · Dec 4, 2025
  • ← Insider ofevidence
    Feider StephenChief Financial Officer · Dec 4, 2025
  • ← Insider ofevidence
    Mensinger MikeChief Product Officer · Dec 4, 2025
  • ← Insider ofevidence
    Lezack AdamDirector · Nov 5, 2025
  • ← Insider ofevidence
    Palasis MariaDirector · Nov 5, 2025